We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Oxford Metrics Plc | OMG | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.90 | 1.85% | 49.45 | 16:35:14 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 49.00 | 48.40 | 49.90 | 49.45 | 48.55 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 20/1/2025 23:05 by lennonsalive Just rereading over the last results again. £46 million cash, although the buy backs will eat into that. Big drop in profits from fy23, hence the cautiousness here of investors. Need another update here to assess |
Posted at 23/5/2024 13:45 by nchanning Don't think any investor wants them to spend 60 million on an acquisition . An occasional bolt on for £10 million is likely to be done at a much more attractive multiple . Immediately returning 30-40 million by tender offer at 120p a share required |
Posted at 08/2/2024 18:51 by crazycoops FYI, Oxford Metrics has been picked as one of Simon Thompson's (of Investors Chronicle) bargain shares for 2024 |
Posted at 11/10/2023 17:27 by nchanning Thanks for all the interesting posts on the business fundamentals you've made here Sceptical Investor |
Posted at 13/6/2023 15:10 by mr dexy Have to say I was very impressed with the Investor Meet presentation yesterday.Worth a watch if you didn't catch it. Regards to all. Mr D |
Posted at 19/10/2021 07:53 by caterham88 Why aren't retail investors invited to participate in today's Capital markets day? |
Posted at 19/10/2021 07:05 by bountyhunter Steady growth over 15 years paying increasing and even special dividends as well but under the radar of most investors? |
Posted at 13/11/2020 13:40 by lignum Re brokers - they meet with management and without being given explicit sensitive information they read between the lines and are steered towards general market dynamics to produce independent forecasts / brokers notes. But I agree that as a private investor it is sometimes possible to do this equally well as an individual. |
Posted at 13/11/2020 10:38 by shieldbug I don't understand what these brokers actually do to communicate the strategy - The company seem to do this quite clearly. Mostly broker's information is not even accessible by retail investors. So that leaves institutions and family offices. Surely these people can read Annual Reports and trading updates?Seriously what do brokers do? |
Posted at 14/9/2020 16:16 by sev22 Fourteen High Quality Small-caps by Algy Hall, Investors Chronicle, 4th September 2020.The impact of Covid-19 has meant I’ve recently needed to change the criteria used by a number of the screens I run, and this week I am having to make a number of alterations to my High Quality Small-cap stock screen. In the case of this screen, the necessity of change in order to generate positive results is perhaps no bad thing. I changed the large-cap version of this quality screen a few years ago and the results have been good, whereas the small-cap screen using the old criteria has failed to impress over the same period. Nevertheless, from a longer-term perspective the screen continues to boast a good record with a cumulative total return since inception in 2012 of 154 per cent compared with 79 per cent from a 50:50 split between the FTSE All Small and Aim indices. While the screen results are meant as a source of ideas for further research rather than an off-the-shelf portfolio, if I factor in a 2 per cent annual charge to represent high small-cap dealing costs, the cumulative total return drops to 116 per cent. The changes I am making to the screen involve: (i) making the key quality criteria more demanding (return on equity and operating margins now need to be in the top quarter rather than top half of stocks screened); (ii) dropping the requirement for sustained improvement in quality due to the impact of Covid and the breadth of the hit across sectors; (iii) changing the forecast growth criteria to one based on the next 24 months to account for expectations of a short-term earnings drop for most companies; (iv) softening the valuation criteria as ‘cheap’ quality shares, while always rare, currently seem very much a thing of the past. The screen’s amended criteria are: PE ratio above bottom fifth and below top fifth of all stocks screened. Earnings growth forecast over the next 24 months. Interest cover of five times or more. Positive free cash flow. Market capitalisation over £20m. A top-quarter return on equity (RoE) in each of the past three years. A top-quarter operating margin in each of the past three years. Operating profit growth over the past three years. In total 14 shares passed the screen’s revamped tests, 12 of which herald from Aim. The results are given in the table below along with fundamental data including the price/earnings ratio (PE) based on forecast annual earnings per share (EPS) 24 months out (referred to in the table as Fwd PE 2-yr rolling). While forecasts that look so far ahead should always be taken with a liberal pinch of salt, especially for under-researched small-caps, this PE still hopefully gives a vague idea of potential valuation after the worst of the Covid hit is out the way. HighQualSmallCaps_fo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
